Triple Bio
PrivateLast Round
Seed
May 20, 2026
Total Funding Raised
$1.7M
Company Overview
Triple Bio operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Seed round in May 2026.
Triple Bio is a biotechnology company that develops lipid-based feed additive platforms to improve productivity and reduce methane emissions in cattle farming.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Carbon Capture
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triple Bio Comparables
Compare Triple Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Agteria Biotech | 86% | |
| Hoofprint Biome | 83% | |
| Number 8 Bio | 82% |
For institutional investors. Book with your work email.
Triple Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Triple Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Positron Ventures | Seed |
| Nucleus Capital | Seed |
| Climate Club | Seed |
Triple Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Triple Bio's valuation, stock price, and market status.
Is Triple Bio a public or private company?
Triple Bio is a private company.
What is the current stock price of Triple Bio?
Triple Bio is a private company, so its shares have no public market price. Caplight tracks Triple Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Triple Bio worth (valuation)?
Valuation information for Triple Bio is not publicly available.
Can I buy Triple Bio stock?
Triple Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Triple Bio's last funding round?
Triple Bio's most recent funding round was Seed on May 20, 2026.
Who are the main investors in Triple Bio?
Key investors in Triple Bio include Positron Ventures, Nucleus Capital, Climate Club.
Will Triple Bio IPO soon?
No public IPO plans have been announced for Triple Bio.
How can I track Triple Bio secondary market activity?
Caplight tracks bids, offers, and trades in Triple Bio's shares on secondary markets.